Yuichi Hashimoto Selected Research

Yuichi Hashimoto Research Topics

Disease

33	Alzheimer Disease (Alzheimer's Disease) 03/2022 - 02/2002
20	Neoplasms (Cancer) 01/2021 - 03/2002
7	Neurodegenerative Diseases (Neurodegenerative Disease) 03/2022 - 03/2013
6	Metabolic Syndrome (Dysmetabolic Syndrome X) 11/2016 - 02/2006
5	Type C Niemann-Pick Disease (Niemann Pick Disease, Type C) 01/2021 - 03/2013
5	Leukemia 05/2015 - 12/2006
4	Dementia (Dementias) 01/2021 - 01/2008
4	Multiple Myeloma 05/2015 - 01/2008
4	Amyotrophic Lateral Sclerosis (Lou Gehrig's Disease) 03/2008 - 11/2004
3	Retinitis Pigmentosa (Pigmentary Retinopathy) 01/2021 - 10/2010
3	Neuroblastoma 07/2012 - 10/2003
3	Diarrhea 12/2010 - 04/2008
3	Acute Promyelocytic Leukemia 07/2009 - 12/2002
3	Juvenile Amyotrophic Lateral Sclerosis 2 03/2008 - 04/2004
3	Amyloid Plaque 05/2006 - 09/2002
2	Carcinogenesis 01/2021 - 01/2009
2	Huntington Disease (Huntington's Disease) 01/2020 - 01/2014
2	Type 2 Diabetes Mellitus (MODY) 01/2017 - 11/2016
2	Dyslipidemias (Dyslipidemia) 01/2017 - 11/2016
2	Inflammation (Inflammations) 01/2017 - 01/2008
2	Non-alcoholic Fatty Liver Disease 01/2017 - 05/2011
2	Inborn Genetic Diseases (Disease, Hereditary) 04/2016 - 09/2013
2	Adult T-Cell Leukemia-Lymphoma (Leukemia Lymphoma, T Cell, Acute, HTLV I Associated) 01/2013 - 07/2009
2	progressive familial intrahepatic 1 Cholestasis 06/2012 - 05/2012
2	Infections 12/2010 - 07/2009
2	Carcinoma (Carcinomatosis) 04/2005 - 05/2002
1	Proteostasis Deficiencies 01/2021
1	Progressive Myoclonic Epilepsies (Progressive Myoclonic Epilepsy) 01/2020
1	Cerebellar Ataxia (Dysmetria) 01/2020
1	Endometriosis 07/2018

Drug/Important Bio-Agent (IBA)

17	humaninIBA 09/2017 - 05/2002
15	Proteins (Proteins, Gene)FDA Link 03/2022 - 02/2002
10	Peptides (Polypeptides)IBA 01/2021 - 05/2002
8	Thalidomide (Thalomid)FDA Link 07/2010 - 12/2002
7	Pharmaceutical PreparationsIBA 01/2021 - 03/2002
5	CholesterolIBA 01/2020 - 07/2009
5	Peroxisome Proliferator-Activated Receptors (PPAR)IBA 01/2017 - 12/2006
5	PresenilinsIBA 03/2012 - 02/2002
5	Amyloid beta-PeptidesIBA 05/2006 - 09/2002
4	LigandsIBA 01/2017 - 01/2008
4	Anesthetics (Anesthetic Agents)IBA 01/2017 - 02/2015
4	Amyloid (Amyloid Fibrils)IBA 06/2016 - 02/2002
4	Flavin-Adenine Dinucleotide (FAD)IBA 08/2004 - 02/2002
3	Calmodulin (Calcium-Dependent Activator Protein)IBA 01/2022 - 09/2017
3	Immunologic Factors (Immunomodulators)IBA 01/2021 - 12/2002
3	Biological ProductsIBA 05/2015 - 01/2008
3	AcidsIBA 05/2011 - 02/2006
3	Antiviral Agents (Antivirals)IBA 12/2010 - 07/2003
3	Androgen Receptors (Androgen Receptor)IBA 07/2008 - 05/2002
3	Superoxide Dismutase-1IBA 03/2008 - 02/2005
3	AndrogensIBA 04/2005 - 05/2002
2	Mutant Proteins (Protein, Mutant)IBA 01/2020 - 09/2013
2	Hormones (Hormone)IBA 07/2018 - 04/2014
2	Membrane Proteins (Integral Membrane Proteins)IBA 01/2017 - 03/2013
2	Cytoplasmic and Nuclear Receptors (Nuclear Receptors)IBA 01/2017 - 01/2008
2	Liver X ReceptorsIBA 01/2017 - 07/2009
2	1'-acetoxychavicol acetateIBA 05/2015 - 10/2008
2	benzohydrol (benzhydrol)IBA 05/2015 - 10/2008
2	Phosphotransferases (Kinase)IBA 12/2014 - 02/2013
2	Muscarinic Receptors (Muscarinic Acetylcholine Receptor)IBA 06/2014 - 11/2005
2	SteroidsIBA 05/2014 - 06/2009
2	TubulinIBA 12/2013 - 11/2002
2	Neuroprotective AgentsIBA 08/2013 - 11/2004
2	Calcitriol Receptors (Calcitriol Receptor)IBA 02/2013 - 06/2008
2	cellular retinoic acid binding protein IIIBA 07/2012 - 04/2010
2	Rhodopsin (Visual Purple)IBA 03/2011 - 10/2010
2	epigallocatechin gallate (epigallocatechin-3-gallate)IBA 02/2009 - 09/2008
2	TeaIBA 02/2009 - 09/2008
2	PyrrolesIBA 07/2008 - 04/2005
2	2- (2,6- diisopropylphenyl)- 5- hydroxy- 1H- isoindole- 1,3- dioneIBA 02/2008 - 01/2008
2	Glucose (Dextrose)FDA LinkGeneric 01/2008 - 08/2007
2	LipidsIBA 01/2008 - 08/2007
2	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 04/2007 - 12/2006
2	PPAR alphaIBA 12/2006 - 02/2006
2	ColivelinIBA 01/2006 - 11/2005
2	activity-dependent neurotrophic factorIBA 11/2005 - 11/2004
2	Amyloid beta-Protein Precursor (Amyloid Protein Precursor)IBA 11/2005 - 04/2004
2	AminopeptidasesIBA 09/2004 - 04/2003
2	Presenilin-2IBA 08/2004 - 03/2002
2	Insulin-Like Growth Factor I (IGF-1)IBA 04/2004 - 02/2004
2	Pertussis ToxinIBA 03/2002 - 02/2002
1	diazonaphthalenedisulfonic acid (NDS)IBA 03/2022
1	AminesIBA 01/2021
1	DNA (Deoxyribonucleic Acid)IBA 01/2021
1	CollagenIBA 01/2021
1	2- amino- 6- methyldipyrido(1,2- a- 3',2'- d)imidazoleIBA 01/2021
1	AdiponectinIBA 01/2021
1	Proteasome Endopeptidase Complex (Proteasome)IBA 01/2020
1	polyglutamineIBA 01/2020
1	OxysterolsIBA 01/2020
1	atrophin-1IBA 01/2020
1	Ataxin-7IBA 01/2020
1	Ataxin-3IBA 01/2020
1	Progesterone Receptors (Progesterone Receptor)IBA 07/2018
1	Contraceptive Agents (Contraceptives)IBA 07/2018

Therapy/Procedure

9	Therapeutics 01/2020 - 12/2002
3	General Anesthesia 04/2016 - 02/2015
3	Cesarean Section (Caesarean Section) 04/2016 - 06/2013
3	Drug Therapy (Chemotherapy) 01/2013 - 01/2008
1	Subcutaneous Injections 01/2021